Evaluation of an Automated Yeasts Identification System for Identification of Yeast Isolates

Clinical Laboratory
|February 5, 2020
PubMed
Abstract

Insights

The BD Phoenix system accurately identifies common Candida species, crucial for diagnosing invasive candidiasis in immunocompromised patients. This study confirms its reliability in clinical settings.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Mycology

Background:

  • Invasive candidiasis is a major global health-care-associated fungal infection.
  • Immunosuppression and underlying diseases drive the rise in fungal infections.
  • Emerging pathogens like Rhodotorula and Trichosporon species pose risks to immunocompromised individuals.

Purpose of the Study:

  • To evaluate the performance of the BD Phoenix system for identifying Candida species.
  • To compare the BD Phoenix system with standard mycological methods, MALDI TOF MS, and sequence analysis.

Main Methods:

  • 603 fungal isolates from blood cultures (January 2012-January 2018) were analyzed.
  • Identification utilized standard mycological methods, MALDI TOF MS, and the BD Phoenix system.
  • Sequence analysis was performed for discrepant or unidentifiable yeasts.

Main Results:

  • The BD Phoenix system demonstrated high concordance (99.2%) with conventional methods and MALDI TOF MS.
  • Excellent compatibility was observed for key Candida species: C. albicans (100%), C. parapsilosis (100%), C. tropicalis (97.3%), C. glabrata (100%), and C. krusei (96.9%).
  • C. albicans was the most frequently isolated species among the 594 Candida spp. identified.

Conclusions:

  • The BD Phoenix system is a reliable and effective tool for identifying clinically significant Candida species.
  • Its ease of use and accuracy support its application in routine clinical microbiology laboratories.
  • Accurate identification of Candida species is vital for timely and appropriate patient management.